Psilocybin for the Treatment of Patients with Depression and Co-Occurring Alcohol Use Disorder
Johns Hopkins Medicine via YouTube
MIT Sloan: Lead AI Adoption Across Your Organization — Not Just Pilot It
The Investment Banker Certification
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore groundbreaking research on psilocybin therapy through this 41-minute grand rounds presentation from Johns Hopkins Psychiatry and Behavioral Sciences. Learn about the therapeutic potential of psilocybin for treating patients with depression and co-occurring alcohol use disorder as presented by Frederick Barrett, Ph.D. Discover the latest findings in psychedelic therapy research, including clinical trial methodologies, treatment protocols, and outcomes for dual-diagnosis patients. Examine the neurobiological mechanisms underlying psilocybin's therapeutic effects, safety considerations, and the evolving landscape of psychedelic-assisted psychotherapy. Gain insights into how this innovative treatment approach addresses the complex interplay between mood disorders and substance use disorders, and understand the implications for future psychiatric practice and patient care.
Syllabus
Johns Hopkins Psychiatry Grand Rounds | Psilocybin Research - Depression and Alcohol Use Disorder
Taught by
Johns Hopkins Medicine